The interpretation of body-composition metrics in obesity.
文献摘要
Modern obesity care is increasingly therapeutic, longitudinal, and outcome-oriented, yet clinical assessment often remains centered on total body weight and BMI. Although BMI remains useful for screening and population-level risk stratification, it cannot characterize the biological heterogeneity of obesity or the quality of treatment response. Similar BMI values or comparable weight-loss trajectories may reflect markedly different changes in adiposity burden, visceral and ectopic fat, lean tissue, skeletal muscle, hydration status, tissue quality, and functional performance, each with distinct metabolic and clinical implications. This chapter reviews the conceptual and clinical foundations of body composition (BC) assessment in adult obesity, emphasizing its role as a framework for phenotyping, monitoring, and interpreting therapeutic response. We discuss key adiposity-related metrics, including fat mass, visceral adipose tissue, ectopic fat, percent body fat, and fat mass index, and clarify clinically relevant distinctions among fat-free mass, lean mass, appendicular lean mass, and skeletal muscle mass. Particular attention is given to common interpretive errors, including the assumption that lean mass reflects skeletal muscle, the use of percent body fat as a primary longitudinal metric, and the interpretation of lean tissue changes without considering hydration status and fluid distribution. We also examine how different BC methods estimate tissue compartments through distinct models, assumptions, and proprietary algorithms, highlighting why measurements from different techniques or devices should not be used interchangeably for longitudinal monitoring. In the context of modern anti-obesity pharmacotherapy, where substantial weight loss is increasingly achievable, BC assessment can help distinguish preferential adiposity reduction from disproportionate lean tissue loss, fluid-related variability, or emerging functional vulnerability. Finally, we propose a practical multidomain framework for clinical interpretation, integrating adiposity burden and distribution, muscular structure and functional reserve, hydration context, tissue quality, and functional performance. This approach supports a shift from weight-centered monitoring toward a more biologically coherent and clinically actionable model of obesity care, in which treatment success is evaluated not only by the magnitude of weight loss, but also by its quality, safety, durability, and functional implications.